* PDS Biotechnology press release [https://seekingalpha.com/pr/20199124-pds-biotech-reports-second-quarter-2025-financial-results-and-provides-clinical-programs] (NASDAQ:PDSB [https://seekingalpha.com/symbol/PDSB]): Q2 GAAP EPS of -$0.21 beats by $0.02.
* The Company’s cash balance as of June 30, 2025 was $31.9 million, compared to $41.7 million as of December 31, 2024.
MORE ON PDS BIOTECHNOLOGY
* Seeking Alpha’s Quant Rating on PDS Biotechnology [https://seekingalpha.com/symbol/PDSB/ratings/quant-ratings]
* Historical earnings data for PDS Biotechnology [https://seekingalpha.com/symbol/PDSB/earnings]
* Financial information for PDS Biotechnology [https://seekingalpha.com/symbol/PDSB/income-statement]
PDS Biotechnology GAAP EPS of -$0.21 beats by $0.02
Published 2 months ago
Aug 13, 2025 at 11:11 AM
Positive
Auto